Students presented their projects on day 4. During the day 3 grant writing session in which students could work on their projects, a clinician scientist (course director) and MD-PhD student (lead teaching assistant) were available to answer questions and help students. With this approach, we hoped to foster collaboration between students at different levels of training (vertical integration) and from different training backgrounds (horizontal integration). In addition, at least 1 person in the group had grant writing experience. Each group contained at least 1 student with bench research experience and at least 1 student with clinical experience. Students worked in teams of 2 to 5 students. On day 3, expectations for the project were again reviewed and students worked on their projects in diverse teams. On day 1, objectives for the course and the project expectations were described. Students worked in collaborative teams to construct a National Institutes of Health–style specifics aims page on a translational project relevant to T-cell immunology in the treatment of cancer. All received a passing grade of “satisfactory (S).” The course was also CME accredited, and 4 MCGSBS registered students elected to take the course for CME credit as well. There were 2 postbaccalaureate students (Mayo Clinic), 4 MS students (Mayo Clinic), 1 PhD/MS student (Mayo Clinic), 1 resident physician pursuing an MS (Mayo Clinic), 1 fellow physician pursuing an MS (“other” institution), 1 attending physician pursuing an MS (Mayo Clinic), 11 PhD students (Mayo Clinic), 2 PhD/other educational category students (Mayo Clinic/other institution), 1 MD-PhD student (Mayo Clinic), and 1 other educational category student (pharmacist pursuing MS Mayo Clinic) who took the course for MCGSBS credit. Students were recruited to participate in the course through e-mail advertisements through MCGSBS, Mayo Clinic Department of Immunology, Mayo Clinic Department of Molecular Medicine, Mayo Clinic Center for Regenerative Medicine, and Mayo Clinic Division of Hematology, as well as the MCGSBS course catalog. Attendance and completion of the final project were required to achieve a passing “satisfactory (S).”Ī total of 25 trainees participated in the course for MCGSBS credit and were from diverse backgrounds. Coursework was graded dichotomously as either satisfactory (S) or nonsatisfactory (N). Participants were eligible to take the course for 3 credits through MCGSBS. ![]() The 2018 “Regenerative T-Cell Immunology in the Treatment of Cancer” course was a 5-day course that ran November 12 to 16, 2018 took place at MCGSBS in Rochester, MN and was available through videoconferencing to Mayo Clinic in Florida and Arizona sites. The course was hosted and funded by the Department of Immunology and Center for Regenerative Medicine at Mayo Clinic in Rochester, Minnesota. The learning objectives were for students to: (1) discuss the current state of translational T-cell immunology and immunotherapy and (2) assemble into interdisciplinary teams to develop and present a research proposal. The goals of the “Regenerative T-Cell Immunology in the Treatment of Cancer” course were to: (1) provide basic science and medical trainees a knowledge base and increase their interest in translational T-cell therapeutics, (2) foster interdisciplinary interactions, and (3) help trainees begin to master skills critical to sustain careers in translational science.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |